Intelligent Bio Solutions (NASDAQ:INBS) and Alignment Healthcare (NASDAQ:ALHC) Head to Head Analysis

Intelligent Bio Solutions (NASDAQ:INBS) and Alignment Healthcare (NASDAQ:ALHC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation.

Analyst Ratings

This is a breakdown of current ratings for Intelligent Bio Solutions and Alignment Healthcare, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1	0	0	0	1.00
Alignment Healthcare	0	3	6	1	2.80

Alignment Healthcare has a consensus price target of $24.30, suggesting a potential upside of 4.71%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, analysts plainly believe Alignment Healthcare is more favorable than Intelligent Bio Solutions.

Institutional & Insider Ownership

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 1.3% of Intelligent Bio Solutions shares are held by insiders. Comparatively, 5.2% of Alignment Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Risk & Volatility

Intelligent Bio Solutions has a beta of 4.21, meaning that its stock price is 321% more volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500.

Profitability

This table compares Intelligent Bio Solutions and Alignment Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Alignment Healthcare	0.47%	11.50%	1.79%

Earnings and Valuation

This table compares Intelligent Bio Solutions and Alignment Healthcare”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05 million	1.76	-$10.57 million	($12.22)	-0.18
Alignment Healthcare	$3.95 billion	1.21	-$720,000.00	$0.09	257.84

Alignment Healthcare has higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Summary

Alignment Healthcare beats Intelligent Bio Solutions on 13 of the 15 factors compared between the two stocks.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.